Literature DB >> 19257816

Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001.

Jesper Ryg1, Lars Rejnmark, Soren Overgaard, Kim Brixen, Peter Vestergaard.   

Abstract

In patients with prior hip fracture (HFx), little is known about time frame and risk factors of second HFx, as well as the ensuing mortality. The aim of the study was to elucidate the incidence of second HFx and subsequent mortality. All 169,145 patients with a first HFx in Denmark during 1977-2001 were followed for up to 25 yr and compared with the background population. Data on fractures, vital status, comorbidity, redeemed prescriptions, and socio-demographic variables were retrieved from national registers. Median follow-up was 3.8 yr, corresponding to 1,041,177 patient-years. A total of 27,834 patients had a second HFx. The cumulative incidence was 9% after 1 yr and 20% after 5 yr, being significantly higher than expected (2% and 12%, respectively; p < 0.05). The RR of second HFx was 2.2 (95% CI: 2.0-2.5) at 1 yr and did not normalize until 15 yr (RR = 1.01, 95% CI: 1.0-1.02). Risk factors for a second HFx were female sex (HR = 1.36, 95% CI: 1.32-1.40), age (HR = 1.68, 95% CI: 1.60-1.76 in patients >85 yr), alcoholism (HR = 1.61, 95% CI: 1.51-1.72), any prior fracture (HR = 1.08, 95%CI :1.04-1.11), and living alone (HR = 1.06, 95% CI: 1.04-1.09). Both sexes had higher mortality at 1 and 5 yr after a second HFx compared with the background population (men-1 yr: 27% versus 9%, p < 0.05; 5 yr: 64% versus 40%, p < 0.05; women-1 yr: 21% versus 10%, p < 0.05; 5 yr: 58% versus 41%, p < 0.05). Patients with HFx are at 2-fold risk of further HFx and the subsequent mortality is highly increased. We propose that programs for secondary prevention should be developed and tested.

Entities:  

Mesh:

Year:  2009        PMID: 19257816     DOI: 10.1359/jbmr.090207

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  93 in total

1.  The future is physio ….

Authors:  Maureen C Ashe
Journal:  Physiother Can       Date:  2011-01-20       Impact factor: 1.037

2.  Constructing an episode of care from acute hospitalization records for studying effects of timing of hip fracture surgery.

Authors:  Katie J Sheehan; Boris Sobolev; Pierre Guy; Eric Bohm; Erik Hellsten; Jason M Sutherland; Lisa Kuramoto; Susan Jaglal
Journal:  J Orthop Res       Date:  2015-08-11       Impact factor: 3.494

3.  Secular trends of hip fractures in France: impact of changing characteristics of the background population.

Authors:  R Garofoli; M Maravic; A Ostertag; M Cohen-Solal
Journal:  Osteoporos Int       Date:  2018-09-13       Impact factor: 4.507

4.  Using vital statistics to estimate the population-level impact of osteoporotic fractures on mortality based on death certificates, with an application to France (2000-2004).

Authors:  Nelly Ziadé; Eric Jougla; Joël Coste
Journal:  BMC Public Health       Date:  2009-09-17       Impact factor: 3.295

5.  Can Hip Fracture Prediction in Women be Estimated beyond Bone Mineral Density Measurement Alone?

Authors:  Piet Geusens; Tineke van Geel; Joop van den Bergh
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-04       Impact factor: 5.346

Review 6.  Prophylactic augmentation of the osteoporotic proximal femur-mission impossible?

Authors:  Peter Varga; Ladina Hofmann-Fliri; Michael Blauth; Markus Windolf
Journal:  Bonekey Rep       Date:  2016-12-07

7.  Excess mortality associated with second hip fracture.

Authors:  B Sobolev; K J Sheehan; L Kuramoto; P Guy
Journal:  Osteoporos Int       Date:  2015-04-25       Impact factor: 4.507

8.  Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study.

Authors:  W Brozek; B Reichardt; J Zwerina; H P Dimai; K Klaushofer; E Zwettler
Journal:  Osteoporos Int       Date:  2015-11-17       Impact factor: 4.507

9.  Hip fracture epidemiological trends, outcomes, and risk factors, 1970-2009.

Authors:  Ray Marks
Journal:  Int J Gen Med       Date:  2010-04-08

10.  Assessment of individual fracture risk: FRAX and beyond.

Authors:  Joop P W van den Bergh; Tineke A C M van Geel; Willem F Lems; Piet P Geusens
Journal:  Curr Osteoporos Rep       Date:  2010-09       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.